Bacterial Disease Diagnostics Market Trends

  • Report ID: 5206
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Government Initiatives for Better Healthcare– In 2021, the World Health Organization started the initiative Global Health and Peaces to address the critical health needs of people and to address 70% of disease outbreaks under this program. Bacterial illness diagnostics are critical for early diagnosis and prompt management of infections, which coincides with the government's preventative healthcare aims.

  • Increasing Emissions from Vehicles– Motor vehicles emit around 1.5 billion tonnes of greenhouse gases (GHGs) directly into the atmosphere each year. Poor air quality is linked to respiratory problems as well as compromised immune systems, rendering people more susceptible to bacterial illnesses. Therefore, the growing vehicular emissions will increase the need for bacterial disease diagnostics to treat infections.
  • Growing Need for Wastewater Treatment- Around 50% of wastewater generated in the world is carefully treated. To test the effectiveness of water and wastewater treatment, the need for bacterial diagnosis becomes highly important. Screening indicator bacteria levels in wastewater aids in making sure that the outcome of residential and industrial wastewater treatment is safe for discharge into the environment.

Challenges

  • Lack of Skilled Personnel and Adequate Infrastructure- Many developing countries do not have well-established infrastructure for advanced diagnostic technologies. Moreover, there is a lack of funds and skilled people to carry on the procedure effectively.
  • Low Awareness Regarding the Diagnosis of Bacterial Diseases
  • High Cost of Manufacturing

Base Year

2024

Forecast Year

2025-2037

CAGR

7.9%

Base Year Market Size (2024)

USD 3.49 billion

Forecast Year Market Size (2037)

USD 9.38 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of bacterial disease diagnostics is assessed at USD 3.95 billion.

The bacterial disease diagnostics market size was valued at USD 3.49 billion in 2024 and is expected to reach USD 9.38 billion by 2037, registering around 7.9% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of bacterial infection and technological advancement in diagnostic technology will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, due to rising instances of fatal infections caused by bacteria in the region.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos